NEUARTIGES TRITYLSCHUTZMITTEL

European patent · EP3539968 · In force

Register entry

Publication number
EP3539968
Application number
EP17869333
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 10, 2017
Published
Sep 18, 2019
Granted
Jul 14, 2021
Protection ends at the latest
Nov 9, 2037
Next annual fee due
Nov 30, 2026
IPC classes
C07F 7/18 (2006.01)
Priority
JP 2016220173 11.11.2016
JP 2017185936 27.09.2017
PCT application
PCT/JP2017/040598 10.11.2017
PCT publication
WO2018/088527 17.05.2018
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Jan 26, 2024

    Change

    Published in Swissreg on 26.01.2024

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. May 25, 2022

    Change

    Published in Swissreg on 25.05.2022

  6. Jul 14, 2021

    Granted

    Published in Swissreg on 14.07.2021

Parties

Holder

Sekisui Medical Co., Ltd.

1-3, Nihonbashi 2-chome Chuo-ku, Tokyo 103-0027, JP

Inventor

YANO, Shinya

Tokyo 103-0027, JP

KUBOTA, Hideki

Tokyo 103-0027, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.